Borgström F - Search Results

1

Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX(®) in Portugal.

Marques A, Lourenço Ó, Ortsäter G, Borgström F, Kanis JA, da Silva JA. Marques A, et al. Among authors: borgstrom f. Calcif Tissue Int. 2016 Aug;99(2):131-41. doi: 10.1007/s00223-016-0132-8. Epub 2016 Mar 25. Calcif Tissue Int. 2016. PMID: 27016370

2

Cost effectiveness of alendronate for the treatment of male osteoporosis in Sweden.

Borgström F, Johnell O, Jönsson B, Zethraeus N, Sen SS. Borgström F, et al. Bone. 2004 Jun;34(6):1064-71. doi: 10.1016/j.bone.2003.12.028. Bone. 2004. PMID: 15193554

3

Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden: an economic evaluation based on the MORE study.

Borgström F, Johnell O, Kanis JA, Oden A, Sykes D, Jönsson B. Borgström F, et al. Pharmacoeconomics. 2004;22(17):1153-65. doi: 10.2165/00019053-200422170-00005. Pharmacoeconomics. 2004. PMID: 15612833

4

Reassessment of the cost-effectiveness of hormone replacement therapy in Sweden: results based on the Women's Health Initiative randomized controlled trial.

Zethraeus N, Borgström F, Jönsson B, Kanis J. Zethraeus N, et al. Among authors: borgstrom f. Int J Technol Assess Health Care. 2005 Fall;21(4):433-41. doi: 10.1017/S0266462305050609. Int J Technol Assess Health Care. 2005. PMID: 16262965 Clinical Trial.

5

Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK--results based on the Women's Health Initiative randomised controlled trial.

Lekander I, Borgström F, Ström O, Zethraeus N, Kanis JA. Lekander I, et al. Among authors: borgstrom f. Bone. 2008 Feb;42(2):294-306. doi: 10.1016/j.bone.2007.09.059. Epub 2007 Oct 23. Bone. 2008. PMID: 18053789

6

Health economics of osteoporosis.

Borgström F, Kanis JA. Borgström F, et al. Best Pract Res Clin Endocrinol Metab. 2008 Oct;22(5):885-900. doi: 10.1016/j.beem.2008.07.005. Best Pract Res Clin Endocrinol Metab. 2008. PMID: 19028362 Review.

7

FRAX and its applications to clinical practice.

Kanis JA, Oden A, Johansson H, Borgström F, Ström O, McCloskey E. Kanis JA, et al. Among authors: borgstrom f. Bone. 2009 May;44(5):734-43. doi: 10.1016/j.bone.2009.01.373. Epub 2009 Feb 3. Bone. 2009. PMID: 19195497 Review.

8

Cost-effectiveness of hormone replacement therapy for menopausal symptoms in the UK.

Lekander I, Borgström F, Ström O, Zethraeus N, Kanis JA. Lekander I, et al. Among authors: borgstrom f. Menopause Int. 2009 Mar;15(1):19-25. doi: 10.1258/mi.2009.009004. Menopause Int. 2009. PMID: 19237618

9

Cost-effectiveness of hormone therapy in the United States.

Lekander I, Borgström F, Ström O, Zethraeus N, Kanis JA. Lekander I, et al. Among authors: borgstrom f. J Womens Health (Larchmt). 2009 Oct;18(10):1669-77. doi: 10.1089/jwh.2008.1246. J Womens Health (Larchmt). 2009. PMID: 19857096

10

Cost effectiveness of teriparatide and PTH(1-84) in the treatment of postmenopausal osteoporosis.

Borgström F, Ström O, Marin F, Kutahov A, Ljunggren O. Borgström F, et al. J Med Econ. 2010;13(3):381-92. doi: 10.3111/13696998.2010.499072. J Med Econ. 2010. PMID: 20604678 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page